But utreloxastat had little effect on ALS in the phase 2 trial. PTC powered the study to show if twice daily oral dosing of ...
Philadelphia dad Eric Brunner was diagnosed with amyotrophic lateral sclerosis, the fatal disease known as ALS. He wants to ...
Bank of America Securities analyst Tazeen Ahmad maintained a Sell rating on PTC Therapeutics (PTCT – Research Report) yesterday and set a price ...
PTC Therapeutics may reeling from the failure of its amyotrophic lateral sclerosis (ALS) drug utreloxastat yesterday, but the ...
PTC Therapeutics halts Utreloxastat development after ALS trial disappoints. Analysts highlight promising pipeline, including ...
While speaking during a conference, Giancarlo Comi suffered a sudden illness. The Italian luminary of neurology has died. He ...
Live Science on MSN1d
'Exercise juice' released by muscles helps nerves grow, study findsIn a new study of mouse cells, scientists found that both the biochemical and mechanical effects of exercise may help injured ...
Widetrial is supporting an expanded access program (EAP) to bring MN-166 (ibudilast) to ALS patients ineligible for clinical ...
There are now at least two patients who have had Neuralink's brain chip implanted in their head. While there have been some ...
A team at IIT (BHU) is developing a revolutionary cell-based medical device using 3D bioprinting technology aimed at curing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback